Mogrify and Astellas initiate research collaboration on in vivo regenerative medicine approaches to address sensorineural hearing loss
Biopharmaceutical company Mogrify and Astellas Pharma have initiated a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.